Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery
- PMID: 25550757
- PMCID: PMC4273241
- DOI: 10.3762/bjoc.10.308
Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery
Abstract
Fluconazole was studied with two different hydrophilic cyclodextrins (hydroxypropyl-β-cyclodextrin (HPBCD) and sulfobutyl ether-β-cyclodextrin (SBECD)) for the formation of inclusion complexes. HPBCD and SBECD showed low cell cytotoxicity in human keratocytes as assessed by the label-free xCELLigence system for real-time monitoring. The fluconazole-HPBCD complex was incorporated into an ion-sensitive ophthalmic gel composed of the natural polysaccharides gellan gum and κ-carrageenan. This system showed good bioadhesive properties and effective control of fluconazole release.
Keywords: cyclodextrins; eye drops; fluconazole; hydroxypropyl-β-cyclodextrin; sulfobutylether-β-cyclodextrin.
Figures
References
-
- Mravii I, Dekaris I, Gabri N, Romac I, Glavota V, Mlinari E. In: Keratitis. Srinivasan M, editor. InTech; 2012.
LinkOut - more resources
Full Text Sources
Other Literature Sources